Business Wire

Brightcove Launches ‘Ad Monetization’ Service for Media Clients, Establishes Global Advertising Operations Team

7.3.2023 17:15:00 EET | Business Wire | Press release

Share

Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of Brightcove Ad Monetization, a new bespoke service designed for media companies to better monetize their content. To supplement the service, the company also created a new global advertising operations team to support media organizations and help them maximize their advertising strategy and revenue.

“Advertising-supported streaming is a fast-growing, multi-billion-dollar business we have supported for many years,” said Marc DeBevoise, CEO of Brightcove. “As a valued partner to our media customers, Brightcove Ad Monetization extends our commitment to providing them with the best products and services to power their video content, optimize their advertising strategy, and now – for the first time – truly drive and maximize their advertising revenue.”

Brightcove Ad Monetization builds on Brightcove’s recently announced strategic partnership with Magnite, the world's largest independent sell-side advertising platform. Through the integration of Magnite and SpringServe, Brightcove now offers an advertising monetization service with end-to-end solutions for media companies to generate additional revenue from their advertising strategy.

Brightcove Ad Monetization will help media companies realize maximum, measurable returns on advertising with actionable insights. The solution supports the monetization of live and video-on-demand (VOD) content with improved yield optimization to fill unsold ad inventory and increase revenue. It includes client-side advertising insertion (CSAI) and server-side advertising insertion (SSAI) capabilities for web players, iOS, Android and connected TV platforms. Brightcove Ad Monetization also seamlessly integrates into independent and existing advertising servers, including Google Ad Manager and FreeWheel.

Companies that utilize the service will benefit from the expertise of Brightcove and receive direct support from its newly established global advertising operations team. Under the leadership of David Beck, Chief Strategy and Corporate Development Officer, the new team will consult directly with clients to optimize their advertising strategy, budget and content. From onboarding to implementation and refining the strategy, the team will tap into its deep insights and expertise to help customers every step of the way, no matter where they are on their advertising journey.

Beck has appointed Michael Dorf as the first Vice President of Global Ad Operations to build the team and help media companies monetize their content. “Advertising is constantly evolving and increasingly complicated for many media companies. Brightcove is determined to reduce the friction in the process, making it easier and more profitable for our clients,” shared Beck. “To do this, we built a new expert team. I’m excited to welcome Michael Dorf to lead our global advertising operations. His wealth of knowledge and experience in the media and advertising world will help customers better deliver the right ads to the right people to improve delivery and revenue.”

Dorf is an experienced revenue operations leader with 15 years of experience in the industry. He most recently worked at TelevisaUnivision as the Vice President of Revenue Operations, where he successfully rebuilt a cross-functional operations team to support direct and programmatic sales channels. Prior to that, he held various senior leadership roles with FreeWheel, a Comcast company, Condé Nast, and Maker Studios, a subsidiary of The Walt Disney Company.

For more information, visit Brightcove.com.

About Brightcove Inc.

Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow LinkedIn, Twitter, Facebook and Instagram. Visit www.brightcove.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Joseph J. Nuñez, Director of Global Communications and Public Relations
jnunez@brightcove.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye